Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

There are many preclinical and phase 1 cancer treatments/targets with $50-100+ million upfronts. A safe, p53 modulator (2 humans and preclinical studies) is just as tantalizing as many IO assets.

I dont think it is that there was a lack of interest in a deal, I think Leo would be hesitant to do a deal if a simple oral reformulation and phase 2a will increase the partnership value significantly.